DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
Ausgabe 01 ·
Volume 21 ·
März 2024
DOI: 10.1055/s-014-59316
Ausgabe
Meistgelesen
Editorial
5
Für Sie referiert
6
8
8
10
12
13
14
15
16
16
17
18
Gesellschaftsmitteilungen
20
Der interessante Fall
21
Steiner, Jakob;
Talakic, Emina;
Adelsmayr, Gabriel;
Regitnig, Peter;
Fuchsjäger, Michael H:
Übersicht
24
Sauer, Stephanie Tina;
Bley, Thorsten Alexander;
Wenkel, Evelyn;
Wujciak, Detlef;
Platz Batista da Silva, Natascha;
Landwehr, Peter:
Whitepaper: Training in Diagnostic and Interventional Breast Radiology
32
von Fritschen, Uwe;
Kremer, Thomas;
Prantl, Lukas;
Fricke, Alba:
Breast Implant-Associated Tumors
61
Müller, Volkmar;
Fasching, Peter A.;
Nabieva, Naiba;
Fehm, Tanja N.;
Thill, Marc;
Schmidt, Marcus;
Kühn, Thorsten;
Banys-Paluchowski, Maggie;
Belleville, Erik;
Juhasz-Böss, Ingolf;
Untch, Michael;
Kolberg, Hans-Christian;
Harbeck, Nadia;
Aktas, Bahriye;
Stickeler, Elmar;
Kreuzeder, Julia;
Hartkopf, Andreas D.;
Janni, Wolfgang;
Ditsch, Nina:
Systemic Therapy of Premenopausal Patients with Early Stage Hormone Receptor-Positive, HER2-Negative Breast Cancer – Controversies and Standards in Healthcare
Wissenschaftliche Arbeit
40
Jaeger, Bernadette Anna Sophia;
Krawczyk, Natalia;
Japp, Anna Sophia;
Honisch, Ellen;
Köhrer, Karl;
Scheuring, Sibylle;
Petzsch, Patrick;
Neubauer, Hans;
Volkmer, Anne Kathrin;
Esposito, Irene;
Ruckhäberle, Eugen;
Niederacher, Dieter;
Fehm, Tanja:
Whole Exome Analysis to Select Targeted Therapies for Patients with Metastatic Breast Cancer – A Feasibility Study
51
Nabieva, Naiba;
Altmann, Falk;
Apel, Klaus;
Baerens, Dirk-Toralf;
Beha, Michaela;
Belau, Antje;
Busch, Steffi;
Guth, Dagmar;
Heinrich, Georg;
Kreiss-Sender, Janine;
Markmann, Susanne;
Olbermann, Andreas;
Oskay-Özcelik, Gülten;
Schuback, Beatrix;
Steinfeld-Birg, Dieter;
Quiering, Claudia;
Kiss, Ferenc;
Kreuzeder, Julia;
Nuti, Paolo;
Schilling, Jörg:
The Endocrine Treatment Landscape for Patients with HR+ HER2− Early-stage Breast Cancer in Germany Before the Introduction of CDK4/6 Inhibitor Therapy – A Real-World Analysis
